Please Wait.....
Report
Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, Topical, Others), Product (Organic Chemicals, Inorganic Chemicals) - Forecast 2032
Market Report I 2024-09-24 I 262 Pages I Market Research Future
Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, Topical, Others), Product (Organic Chemicals, Inorganic Chemicals) - Forecast 2032
Market Overview
The pharmaceutical excipients market was valued at USD 9.27 billion in 2023 and is expected to rise from USD 10.02 billion in 2024 to USD 18.48 billion by 2032, with a compound annual growth rate (CAGR) of 7.03% during the forecast period (2024-2032). The primary key drivers fueling market expansion are the increased need for multifunctional excipients and the growing use of generic pharmaceuticals.
Furthermore, the pharmaceutical excipients market is used to enhance the flavor of the medicine, which enhances patient compliance, particularly in youngsters. Pharmaceutical excipients can come from either organic or inorganic sources, depending on their chemical composition. The primary drivers of the pharmaceutical excipients market are increased need for functional excipients, recent patent expirations that increase consumer demand for pharmaceutical excipients, and the rapid development of nanotechnology. Excipients can be added to solid formulations containing moderate APIs to improve long-term stability, increase the potency of the active component in the finished dosage form, or for any other purpose. Excipients are also used to improve the properties of pharmaceutical formulations, such as improving drug absorption, decreasing viscosity, and increasing API solubility.
Market Segment insights
Pharmaceutical excipients are classified into market sectors based on their functions, such as fillers, binders, coatings, disintegrants, preservatives, and others.
The Pharmaceutical Excipients market data divides by-products into organic and inorganic compounds.
The pharmaceutical excipients market is divided into four segments based on application: oral, topical, parenteral, and others.
Regional insights
The study's regional market insights encompass Asia-Pacific, Europe, North America, and the rest of the world. In 2022, the Europe Pharmaceutical Excipients market was valued at USD 2.51 billion and was expected to grow at a significant CAGR. Because of looming drug patent expiration dates, many European governments are focusing on the generics market. As a result, European countries such as Germany, the United Kingdom, France, and others are expected to see strong growth rates over the forecast period. Pharmaceutical excipients are expected to be in high demand in this field.
The pharmaceutical excipients market in North America is the second largest. The constantly increasing pharmaceutical sector, increased demand for functional excipients, strong competitors in the field, and technical advancements will all have a substantial impact on the market's growth over the projection period.
The pharmaceutical excipients market in Asia-Pacific is expected to grow at the fastest CAGR between 2024 and 2032. A recent analysis found that China's overall traditional pharmaceutical sales revenue will continue to rise in the next years.
Major Players
Key players in the Pharmaceutical Excipients market are Evonik Industries AG, Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, FMC Corporation, The Dow Chemical Company, Ashland, Inc., and Croda International PLC, among others.
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.2.1. RESEARCH OBJECTIVE
2.2.2. ASSUMPTIONS
2.2.3. LIMITATIONS
3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
3.6.1. BOTTOM-UP APPROACH
3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION
4. MARKET DYNAMICS
4.1. OVERVIEW
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES
5. MARKET FACTOR ANALYSIS
5.1. VALUE CHAIN ANALYSIS
5.2. PORTER'S FIVE FORCES ANALYSIS
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
5.3.1. MARKET IMPACT ANALYSIS
5.3.2. REGIONAL IMPACT
5.3.3. OPPORTUNITY AND THREAT ANALYSIS
6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE
6.1. OVERVIEW
6.2. PHARMACEUTICAL FILLERS
6.3. BINDERS
6.4. COATINGS
6.5. DISINTEGRANTS
6.6. PRESERVATIVES
6.7. OTHERS
7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT
7.1. OVERVIEW
7.2. ORGANIC CHEMICALS
7.3. INORGANIC CHEMICALS
8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. ORAL
8.3. TOPICAL
8.4. PARENTERAL
8.5. OTHERS
9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION
9.1. OVERVIEW
9.1. NORTH AMERICA
9.1.1. US
9.1.2. CANADA
9.2. EUROPE
9.2.1. GERMANY
9.2.2. FRANCE
9.2.3. UK
9.2.4. ITALY
9.2.5. SPAIN
9.2.6. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. CHINA
9.3.2. INDIA
9.3.3. JAPAN
9.3.4. SOUTH KOREA
9.3.5. AUSTRALIA
9.3.6. REST OF ASIA-PACIFIC
9.4. REST OF THE WORLD
9.4.1. MIDDLE EAST
9.4.2. AFRICA
9.4.3. LATIN AMERICA
10. COMPANY LANDSCAPE
10.1. OVERVIEW
10.2. COMPETITIVE ANALYSIS
10.3. MARKET SHARE ANALYSIS
10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
10.5. COMPETITIVE BENCHMARKING
10.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
10.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
10.7.1. NEW PRODUCT LAUNCH
10.7.2. MERGER & ACQUISITIONS
10.7.3. JOINT VENTURES
10.8. MAJOR PLAYERS FINANCIAL MATRIX
10.8.1. SALES & OPERATING INCOME, 2022
10.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022
11. COMPANY PROFILES
11.1. EVONIK INDUSTRIES AG
11.1.1. COMPANY OVERVIEW
11.1.2. FINANCIAL OVERVIEW
11.1.3. PRODUCT OFFERED
11.1.4. KEY DEVELOPMENTS
11.1.5. SWOT ANALYSIS
11.1.6. KEY STRATEGIES
11.2. BASF SE
11.2.1. COMPANY OVERVIEW
11.2.2. FINANCIAL OVERVIEW
11.2.3. PRODUCT OFFERED
11.2.4. KEY DEVELOPMENTS
11.2.5. SWOT ANALYSIS
11.2.6. KEY STRATEGIES
11.3. FERRO CORPORATION
11.3.1. COMPANY OVERVIEW
11.3.2. FINANCIAL OVERVIEW
11.3.3. PRODUCT OFFERED
11.3.4. KEY DEVELOPMENTS
11.3.5. SWOT ANALYSIS
11.3.6. KEY STRATEGIES
11.4. P&G CHEMICALS
11.4.1. COMPANY OVERVIEW
11.4.2. FINANCIAL OVERVIEW
11.4.3. PRODUCT OFFERED
11.4.4. KEY DEVELOPMENTS
11.4.5. SWOT ANALYSIS
11.4.6. KEY STRATEGIES
11.5. FMC CORPORATION
11.5.1. COMPANY OVERVIEW
11.5.2. FINANCIAL OVERVIEW
11.5.3. PRODUCT OFFERED
11.5.4. KEY DEVELOPMENTS
11.5.5. SWOT ANALYSIS
11.5.6. KEY STRATEGIES
11.6. THE DOW CHEMICAL COMPANY
11.6.1. COMPANY OVERVIEW
11.6.2. FINANCIAL OVERVIEW
11.6.3. PRODUCT OFFERED
11.6.4. KEY DEVELOPMENTS
11.6.5. SWOT ANALYSIS
11.6.6. KEY STRATEGIES
11.7. ASHLAND, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. FINANCIAL OVERVIEW
11.7.3. PRODUCT OFFERED
11.7.4. KEY DEVELOPMENTS
11.7.5. SWOT ANALYSIS
11.7.6. KEY STRATEGIES
11.8. CRODA INTERNATIONAL PLC
11.8.1. COMPANY OVERVIEW
11.8.2. FINANCIAL OVERVIEW
11.8.3. PRODUCT OFFERED
11.8.4. KEY DEVELOPMENTS
11.8.5. SWOT ANALYSIS
11.8.6. KEY STRATEGIES
11.9. AKZO NOBEL NV
11.9.1. COMPANY OVERVIEW
11.9.2. FINANCIAL OVERVIEW
11.9.3. PRODUCT OFFERED
11.9.4. KEY DEVELOPMENTS
11.9.5. SWOT ANALYSIS
11.9.6. KEY STRATEGIES
11.10. INNOPHOS
11.10.1. COMPANY OVERVIEW
11.10.2. FINANCIAL OVERVIEW
11.10.3. PRODUCT OFFERED
11.10.4. KEY DEVELOPMENTS
11.10.5. SWOT ANALYSIS
11.10.6. KEY STRATEGIES
12. APPENDIX
12.1. REFERENCES
12.2. RELATED REPORTS
LIST OF TABLES
TABLE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 9 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 10 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 11 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 12 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 13 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 14 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 15 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 16 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 17 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
TABLE 18 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 19 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 20 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 21 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 22 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 23 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 24 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 25 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 26 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 27 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 28 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 29 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 30 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 31 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 32 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 33 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 34 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 35 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 36 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 37 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 38 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 39 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 40 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 41 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 42 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 43 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 44 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 45 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 46 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 47 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 48 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 49 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 50 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 51 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 52 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 53 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 54 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 55 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 56 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 57 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 58 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 59 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 60 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 61 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 62 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 63 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
TABLE 64 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 65 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 68 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 69 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 70 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 71 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 72 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 73 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 74 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 75 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY FUNCTION, 2022
FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 9 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 12 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS (%), 2022
FIGURE 13 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 EVONIK INDUSTRIES AG: SWOT ANALYSIS
FIGURE 15 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BASF SE: SWOT ANALYSIS
FIGURE 17 P&G CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 P&G CHEMICALS: SWOT ANALYSIS
FIGURE 19 AKZO NOBEL NV, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AKZO NOBEL NV, INC: SWOT ANALYSIS
FIGURE 21 FMC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 FMC CORPORATION: SWOT ANALYSIS
FIGURE 23 THE DOW CHEMICAL COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 THE DOW CHEMICAL COMPANY: SWOT ANALYSIS
FIGURE 25 ASHLAND, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ASHLAND, INC.: SWOT ANALYSIS
FIGURE 27 CRODA INTERNATIONAL PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 CRODA INTERNATIONAL PLC: SWOT ANALYSIS
FIGURE 29 FERRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 FERRO CORPORATION: SWOT ANALYSIS
FIGURE 31 INNOPHOS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 INNOPHOS: SWOT ANALYSIS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security